XBiotech (XBIT) Share-based Compensation (2014 - 2026)
XBiotech (XBIT) reported Share-based Compensation of $172,000 for Q2 2026, up 60.7% from $107,000 a year earlier.
Powered by 
Analysis
XBiotech (XBIT) Share-based Compensation (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, XBiotech's Share-based Compensation came in at $465,000, down 89.5% year-over-year; for FY2025, it came in at $3.62 million, up 106.6% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of -22.0% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $1.75 million in FY2024 (-46.3%), $3.26 million in FY2023 (-35.6%), $5.06 million in FY2022 (+13.4%) and $4.46 million in FY2021 (-64.5%).
- The Q2 2026 figure ranks as the highest quarterly Share-based Compensation since Q1 2025.
- Year over year, Share-based Compensation gained in two of the last seven quarters, with growth averaging 74.9%.
- The high point for year-over-year Share-based Compensation in five years was Q1 2025 (growth of 773.8%); the low point was Q3 2025 (a decline of 93.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | XBiotech | 58.23 Mn | -439.75 Mn | - | 172,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 172,000.00 |
| Dec 31, 2025 | 162,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 107,000.00 |
| Mar 31, 2025 | 3.33 Mn |
| Dec 31, 2024 | 628,000.00 |
| Sep 30, 2024 | 365,000.00 |
| Jun 30, 2024 | 379,000.00 |
| Mar 31, 2024 | 381,000.00 |
| Dec 31, 2023 | 688,000.00 |
| Sep 30, 2023 | 955,000.00 |
| Jun 30, 2023 | 914,000.00 |
| Mar 31, 2023 | 705,000.00 |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 1.45 Mn |
| Dec 31, 2021 | 1.35 Mn |
| Sep 30, 2021 | 1.13 Mn |
| Jun 30, 2021 | 1.04 Mn |
API Access
XBiotech Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();